San Diego, CA, United States of America

Todd Merrill Binder

USPTO Granted Patents = 2 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2022-2023

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Todd Merrill Binder

Introduction: Todd Merrill Binder is a prominent inventor based in San Diego, California. With a keen focus on advancements in cancer treatment, he has made significant strides in the field of immunotherapy. His innovative approach is reflected in his two patents, which showcase his commitment to developing effective therapies for combating cancer.

Latest Patents: Todd's latest patents revolve around an allogeneic whole cell cancer vaccine platform. This groundbreaking invention involves compositions and methods for treating and preventing cancer. The technology includes a therapeutically effective amount of cells derived from one or more cancer cell lines, modified to inhibit or reduce expression of immunosuppressive factors. Furthermore, these cells express or increase immunostimulatory factors and tumor-associated antigens (TAAs), including those that have been mutated. This innovative vaccine platform not only enhances the body's immune response but also tackles the diversity of tumor-associated antigens and neoantigens found within cancer cells.

Career Highlights: Todd Merrill Binder is currently employed at Neuvogen, Inc., where he plays a crucial role in developing advanced cancer treatment solutions. His work on tumor cell vaccines is instrumental in paving the way for new therapeutic options that could significantly improve patient outcomes in cancer care.

Collaborations: Throughout his career, Todd has collaborated with esteemed professionals in the field, such as Bernadette Ferraro and Matthias Hundt. These collaborations have bolstered his innovative projects and contributed to the advancement of cancer immunotherapy.

Conclusion: Todd Merrill Binder's inventive contributions to cancer treatment exemplify the potential of innovation in the medical field. His work on allogeneic whole cell cancer vaccines demonstrates a promising frontier in immunotherapy, aimed at enhancing the body's ability to fight cancer. As he continues to develop and refine his inventions, Todd's impact on healthcare and cancer treatment is sure to grow, offering hope to many patients and advancing scientific understanding in oncology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…